Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02326636 · ClinicalTrials.gov registry record
Fecal Microbiota Transplant for Recurrent Clostridium Difficile Infection
A clinical trial, sponsored by University of California, Irvine.
- Completed
- Registry status
- 37
- Enrollment target
NCT02326636 is a clinical trial that has completed, run by University of California, Irvine. The registered enrollment target is 37 participants.
The verdict
NCT02326636 has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- 37 participants
- Enrollment target
Study Summary
The purpose of this research is to investigate the efficacy of transplanting screened donor fecal material in treating patients with recurrent Clostridium difficile infection. Participants with refractory Clostridium difficile infection will be given healthy donor stool administered by colonoscopy or enema and their response will be evaluated by symptom questionnaire and stool testing for Clostridium difficile at 4 weeks after the treatment.
Interventions
- BIOLOGICAL Fecal Microbial Transplantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2014-04 |
| Est. Completion | 2018-10-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02326636
The ClinicalTrials.gov registry entry for NCT02326636 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fecal Microbial Transplantation is the first listed.
NCT02326636 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02326636 about?
NCT02326636 is a clinical study titled "Fecal Microbiota Transplant for Recurrent Clostridium Difficile Infection". The purpose of this research is to investigate the efficacy of transplanting screened donor fecal material in treating patients with recurrent Clostridium difficile infection. Participants with refractory Clostridium difficile infection will be given healthy donor stool administered by colonoscopy o...
What is the current status of trial NCT02326636?
This trial is currently completed. The enrollment target is 37 participants. The study started on 2014-04. Estimated completion is 2018-10-26.
What interventions are being tested in trial NCT02326636?
The interventions under investigation include: Fecal Microbial Transplantation (BIOLOGICAL).
Who is sponsoring clinical trial NCT02326636?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.